Stephen A. Byeff
  1. Associate

Mr. Byeff is an associate in Davis Polk's Corporate Department, practicing in the Capital Markets Group. His practice includes advising U.S. and non-U.S. clients across a variety of industries on capital markets transactions, including initial public offerings and other equity offerings and public and private high-yield, investment-grade and convertible debt offerings. He also advises clients on governance, corporate and securities law matters. His practice ranges across a variety of industries, including consumer, retail, food and beverage, technology, industrials, biotech, pharmaceuticals and financial services. 

Work Highlights

CAPITAL MARKETS TRANSACTIONS
  • IPOs for Collier Creek Holdings, Hudson Ltd., Dova Pharmaceuticals and Mersana Therapeutics
  • Equity offerings for International Flavors & Fragrances, RealPage, General Mills and XPO
  • Investment grade and high-yield debt offerings (including in connection with acquisition financings) for Bausch Health Companies, Brookfield Business Partners, General Mills, Discovery Communications, International Flavors & Fragrances, The Bank of N.T. Butterfield & Son, GeoPark Limited and Textron
OTHER
  • Public reporting, securities compliance and corporate governance advice for a variety of large, mid and small cap companies, including Bausch Health Companies, Hudson Ltd., Verisk Analytics and Clarios Power Solutions

Professional History

  • Davis Polk since 2015

Practice Focus

Bar Admissions

  • State of New York

Education

  • B.A., International Studies, Johns Hopkins University, 2009
  • M.A., International Relations, Economics, Johns Hopkins School of Advanced Int'l Studies, 2011
  • J.D., Columbia Law School, 2015
    • Edwin Parker Prize, Int'l and Comparative Law
    • James Kent Scholar
    • Senior Editor, Columbia Law Review